No INR, no target, no bleeding surveillance, no MDS support — the skilled monitoring is invisible.
The warfarin model note in §3: the INR against the target, the protocol-based dose decision, the bleeding surveillance, and the reason daily monitoring was skilled.
“No bleeding noted.”
No specifics of what was surveyed.
“No bruising, epistaxis, hematuria, or melena; no new interacting medications; fall precautions in place.”
“INR high.”
No value, no target, no protocol action, no monitoring.
“INR 5.2 (target 2.0–3.0), no active bleeding → warfarin held per protocol → provider notified; hold ± vitamin K and repeat INR ordered; bleeding precautions.”
